Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Alkermes plc (ALKS)

  • SEC News
  • Oct. 28, 2025, 13:21 UTC
  • 1
  • 0 comments

New Form 10-Q - Alkermes plc. Filed: 2025-10-28 AccNo: 0001193125-25-252524 Size: 15 MB

Comment Full text

ESSA Pharma Inc (EPIX)

  • SEC News
  • Oct. 28, 2025, 13:11 UTC
  • 1
  • 0 comments

New Form 15-12G - ESSA Pharma Inc. Filed: 2025-10-28 AccNo: 0001104659-25-102922 Size: 10 KB

Comment Full text

IX Biopharma LTD. (42C)

  • SEC News
  • Oct. 28, 2025, 13:09 UTC
  • 1
  • 0 comments

General Announcement: Request for Lifting of Trading Halt - Sponsors Statement

Comment Full text

IX Biopharma LTD. (42C)

  • SEC News
  • Oct. 28, 2025, 13:09 UTC
  • 1
  • 0 comments

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

Comment Full text

IX Biopharma LTD. (42C)

  • SEC News
  • Oct. 28, 2025, 13:08 UTC
  • 0
  • 0 comments

Placements: Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Results of Proposed Placement

Comment Full text

Integrated BioPharma, Inc. (INBP)

  • SEC News
  • Oct. 28, 2025, 13:05 UTC
  • 0
  • 0 comments

New Form DEF 14A - INTEGRATED BIOPHARMA INC Filed: 2025-10-28 AccNo: 0001437749-25-031864 Size: 968 KB

Comment Full text

Vivani Medical Inc. (VANI)

  • SEC News
  • Oct. 28, 2025, 13:00 UTC
  • 0
  • 1 comments

Director Williams Gregg 🟢 acquired 3.7M shares of Vivani Medical, Inc. (VANI) at $1.62 ($6.0M) Transaction Date: Oct 27, 2025 | Filing ID: 001658

Comment Full text

Tourmaline Bio Inc (TRML)

  • SEC News
  • Oct. 28, 2025, 12:58 UTC
  • 0
  • 0 comments

New Form 25-NSE - Tourmaline Bio, Inc. Filed: 2025-10-28 AccNo: 0001354457-25-001066 Size: 3 KB

Comment Full text

Cybin Inc (CYBN)

  • SEC News
  • Oct. 28, 2025, 12:52 UTC
  • 0
  • 0 comments

New Form 6-K - CYBIN INC. Filed: 2025-10-28 AccNo: 0001833141-25-000027 Size: 68 KB

Comment Full text

Neogen Corporation (NEOG)

  • SEC News
  • Oct. 28, 2025, 12:51 UTC
  • 0
  • 1 comments

Director Pelossof Avi 🟢 acquired 69.3K shares (1 derivative) of NEOGEN CORP (NEOG) at $6.19 Transaction Date: Oct 24, 2025 | Filing ID: 000058

Comment Full text
  • Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next

Search

News categories

  • Technical Exchange News(10279)
  • Event(1436)
  • SEC News(174561)
  • FDA Approval(9627)
  • Company Report(721)
  • Business News(117175)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin